Improving chemotherapy capacity by switching from IV to oral vinorelbine

Oral vinorelbine reduced the time spent by patients and pharmacists in chemotherapy delivery but care pathways differed across the EU facilities studied. Possible reasons include differing organisation and competency frameworks.